Zhongzhi Pharmaceutical Holdings バランスシートの健全性
財務の健全性 基準チェック /56
Zhongzhi Pharmaceutical Holdingsの総株主資本はCN¥1.1B 、総負債はCN¥74.6Mで、負債比率は6.7%となります。総資産と総負債はそれぞれCN¥2.0BとCN¥850.0Mです。 Zhongzhi Pharmaceutical Holdingsの EBIT はCN¥107.6Mで、利息カバレッジ比率42.8です。現金および短期投資はCN¥198.9Mです。
主要情報
6.7%
負債資本比率
CN¥74.57m
負債
| インタレスト・カバレッジ・レシオ | 42.8x |
| 現金 | CN¥198.92m |
| エクイティ | CN¥1.11b |
| 負債合計 | CN¥850.02m |
| 総資産 | CN¥1.96b |
財務の健全性に関する最新情報
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24
Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Recent updates
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding
Aug 22Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Jun 19Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation
May 10Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
May 05Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
Apr 21Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares
Feb 01These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)
May 06Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues
Apr 21Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?
Mar 29The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More
Mar 05Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Feb 15
What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?
Jan 14Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?
Dec 27If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late
Dec 14Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?
Nov 30Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 17財務状況分析
短期負債: 3737の 短期資産 ( CN¥976.9M ) が 短期負債 ( CN¥700.2M ) を超えています。
長期負債: 3737の短期資産 ( CN¥976.9M ) が 長期負債 ( CN¥149.8M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: 3737総負債よりも多くの現金を保有しています。
負債の削減: 3737の負債対資本比率は、過去 5 年間で0%から6.7%に増加しました。
債務返済能力: 3737の負債は 営業キャッシュフロー によって 十分にカバー されています ( 226.2% )。
インタレストカバレッジ: 3737の負債に対する 利息支払い は EBIT ( 42.8 x coverage) によって 十分にカバーされています。